NCT07531589 BrainLive Connect: Non-professional Delivered CST for People Living With Dementia
| NCT ID | NCT07531589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 520 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2027-11-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 520 participants in total. It began in 2026-03-31 with a primary completion date of 2027-11-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this mixed method study is to evaluate whether the volunteer-led Cognitive Stimulation Therapy (CST) under the BrainLive Connect programme is effective for improving cognitive function and quality of life of people living with dementia (PLwD). The main question it aims to answer are: • Do PLwD receiving the BrainLive Connect service show better cognitive function and quality of life than those receiving usual care? Researchers will compare BrainLive Connect service to usual care to see whether the intervention leads to better outcomes. Participants will: * Receive either 7 weeks of BrainLive Connect sessions delivered by trained volunteers or continue receiving usual care. * Be assessed at baseline (T0), post-intervention (7 weeks; T1), and 1 month follow up (11 weeks; T2). * Take part in semi-strucutred interviews post-intervention to provide feedback on implementation and areas for improvement.
Eligibility Criteria
Inclusion Criteria: PLwD: Hong Kong residents, mild to moderate dementia, either having i) a formal diagnosis, or 2) suspected dementia reported by care professionals and screened by Montreal Cognitive Assessment (MoCA). Family carers: self-identified as the primary carer of the PLwD. Exclusion Criteria: Unable to communicate and participate in interviews/training/intervention due to hearing impairment, visual impairment, or other conditions.
Contact & Investigator
Shiyu LU
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT07531589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07531589 currently recruiting?
Yes, NCT07531589 is actively recruiting participants. Contact the research team at cpchoy@hku.hk for enrollment information.
Where is the NCT07531589 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07531589 clinical trial?
NCT07531589 is sponsored by The University of Hong Kong. The principal investigator is Shiyu LU at The University of Hong Kong. The trial plans to enroll 520 participants.